Literature DB >> 9760999

Increased expression of beta-hexosaminidase alpha chain in cultured skin fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome type I.

S Ichisaka1, K Ohno, I Yuasa, E Nanba, H Sakuraba, Y Suzuki.   

Abstract

Carbohydrate-deficient glycoprotein (CDG) syndrome type I is an autosomal recessive multisystem disorder characterized by multiple serum glycoproteins with deficient oligosaccharide chains. This characteristic under-glycosylation is found in several serum glycoproteins. We studied secreted forms of lysosomal enzymes, beta-hexosaminidase and alpha-fucosidase, in serum from the patients and media of cultured fibroblasts. Both beta-hexosaminidase and alpha-fucosidase activities were increased in sera from three CDG patients. The enzyme activity staining using the fluorogenic substrate-4-methylumbelliferyl-alpha-L-fucopyranoside after polyacrylamide gel isoelectric focusing revealed abnormal cathodal bands in sera from CDG patients. On the other hand, no abnormal secreted forms of beta-hexosaminidase and alpha-fucosidase were detected in media from cultured CDG fibroblasts by isoelectric focusing and sodium-dodecyl sulfate-polyacrylamide gel electrophoresis. However, SDS-polyacrylamide gel electrophoresis and Western blotting analysis of beta-hexosaminidase using anti-beta-hexosaminidase A (anti-alpha + beta chains) antibody, showed an increase of a 55-kDa mature form of the alpha chain. Northern blotting analysis identified an increase in mRNA levels of beta-hexosaminidase alpha chain in CDG fibroblasts. Although under-glycosylated fractions of these lysosomal enzymes were not detected in cultured fibroblasts, it was suggested that intracellular processing of these lysosomal enzymes in CDG patients might be altered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760999     DOI: 10.1016/s0387-7604(98)00035-7

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

1.  Abnormal lysosomal inclusions in liver hepatocytes but not in fibroblasts in congenital disorders of glycosylation (CDG).

Authors:  S Grünewald; R De Vos; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.

Authors:  Hiromi Akeboshi; Yasunori Chiba; Yoshiko Kasahara; Minako Takashiba; Yuki Takaoka; Mai Ohsawa; Youichi Tajima; Ikuo Kawashima; Daisuke Tsuji; Kohji Itoh; Hitoshi Sakuraba; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

3.  Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity.

Authors:  Aurélie Cazet; Jonathan Charest; Daniel C Bennett; Cecilia Lopez Sambrooks; Joseph N Contessa
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.